No not really. Nothing to wonder about. This is the OTC. Institutional buyers can't buy. Mostly the pump and dump crowd, or the actual investors that are waiting for the final ascent upwards to where it will stay. No arguing that this is in the hands of the company. Some of the answers are not the most favorable but it is designed to get the job done.